- Research article
- Open Access
- Open Peer Review
In vitro and in vivo reduction of post-prandial blood glucose levels by ethyl alcohol and water Zingiber mioga extracts through the inhibition of carbohydrate hydrolyzing enzymes
BMC Complementary and Alternative Medicinevolume 16, Article number: 111 (2016)
Type 2 diabetes is a serious problem for developed and developing countries. Prevention of prediabetes progression to type 2 diabetes with the use of natural products appears to be a cost-effective solution. Zingiber mioga has been used as a traditional food in Asia. Recent research has reported the potential health benefits of Zingiber mioga, but the blood glucose reducing effect has not been yet evaluated.
In this study Zingiber mioga extracts (water and ethanol) were investigated for their anti-hyperglycemic and antioxidant potential using both in vitro and animal models. The in vitro study evaluated the total phenolic content, the oxygen radical absorbance capacity (ORAC) and the inhibitory effect against carbohydrate hydrolyzing enzymes (porcine pancreatic α-amylase and rat intestinal sucrase and maltase) of both Zingiber mioga extracts. Also, the extracts were evaluated for their in vivo post-prandial blood glucose reducing effect using SD rat and db/db mice models.
Our findings suggest that the ethanol extract of Zingiber mioga (ZME) exhibited the higher sucrase and maltase inhibitory activity (IC50, 3.50 and 3.13 mg/mL) and moderate α-amylase inhibitory activity (IC50, >10 mg/mL). Additionally, ZME exhibited potent peroxyl radical scavenging linked antioxidant activity (0.53/TE 1 μM). The in vivo study using SD rat and db/db mice models also showed that ZME reduces postprandial increases of blood glucose level after an oral administration of sucrose by possibly acting as an intestinal α-glucosidase inhibitor (ZME 0.1 g/kg 55.61 ± 13.24 mg/dL)
The results indicate that Zingiber mioga extracts exhibited significant in vitro α-glucosidase inhibition and antioxidant activity. Additionally, the tested extracts demonstrated in vivo anti-hyperglycemic effects using SD rat and db/db mice models. Our findings provide a strong rationale for the further evaluation of Zingiber mioga for the potential to contribute as a useful dietary strategy to manage postprandial hyperglycemia.
Non-insulin dependent diabetes mellitus (NIDDM, Type 2 diabetes) is a group of metabolic diseases marked by high levels of blood glucose resulting from faults in insulin resistance and insulin production [1–3]. Hyperglycemia, a rapid rise in blood glucose levels in NIDDM patients occurs due to hydrolysis of starch by pancreatic α-amylase and absorption of glucose in the small intestine by α-glucosidases such as sucrase and maltase . Inhibition of these carbohydrate-hydrolyzing enzymes can significantly decrease the postprandial hyperglycemia after a mixed carbohydrate diet and can be a key strategy in the control of diabetes mellitus [4, 5]. However, a main negative aspect of currently used therapeutic α-glucosidase inhibitors, such as the drug acarbose, is the strong α-amylase inhibitory activity causing abnormal bacterial fermentation of undigested starch in the colon that leads to abdominal distention, flatulence, meteorism and possibly diarrhea [6, 7]. Recent studies showed that phenolic phytochemicals from plant sources are natural inhibitors of α-amylase and α-glucosidase [8, 9] Such natural inhibitors from dietary plants could be useful since they have lower inhibitory activity against α-amylase and a stronger inhibitory activity against α-glucosidase and can be potentially used as an effective strategy for the management of postprandial hyperglycemia with minimal side effects .
Zingiber mioga (Zingiberaceae family) is a herb original to eastern Asia. Its young flower buds have been used as a traditional food in Asia . Recent research has reported the antimicrobial activities of the constituents of Zingiber mioga against several strains of bacteria, yeast, and mold [11, 12]. The volatile ingredients of Zingiber mioga have been studied; 2-isopropyl-3-methoxypyrazine, 2-sec-butyl-3-methoxypyrazine, and 2-isobutyl-3-methoxypyrazine were found to be the aroma compounds by GC-MS . Additionally, mioga extract was effective in inhibiting fat accumulation in 3 T3-L1 adipocytes leading to a decrease in body weight gain and a decrease in fat mass in ICR mice . However, the significance of Zingiber mioga intake for preventing diabetes-related oxidative stress and hyperglycemia is not reported. Based on the previous obesity related findings, it is interesting to first evaluate the in vitro potential of mioga extracts again carbohydrate hydrolyzing enzyme using in vitro models and if inhibitory effect is observed, then the extracts should be evaluated using an animal model.
Therefore, the aim of this study is to examine the potential effect and mechanism of action of Zingiber mioga extract on the inhibition of postprandial hyperglycemia using both in vitro and in vivo animal models. Clear knowledge of the activity and mode of action of Zingiber mioga extract will contribute towards better understanding of the actual effect of various Zingiber mioga products towards type 2 diabetes management. To determine the above, in this study, we (i) prepared Zingiber mioga extracts (water extract of Zingiber mioga: ZMW, ethanol extract of Zingiber mioga: ZME); (ii) investigated the inhibitory activity of ZMW, ZME against α-amylase and α-glucosidase (anti-hyperglycemia potential); (iii) measured antioxidant potential using oxygen radical scavenging capacity (ORAC) assay; and (iv) evaluated the postprandial blood glucose lowering effect of ZMW, ZME after sucrose loading in a Sprague-Dawley (SD) rat and db/db mice model.
Zingiber mioga was obtained from a local market in Jeju, Korea. The purchased samples were identified by one of the authors (Young-In Kwon). A voucher specimen (BFC O10985) was deposited at the Bioactive Food Components Lab (BFCL) of the College of Life Science and Nano Technology, Hannam University. Rat intestinal acetone powder, porcine pancreatic α-amylase enzyme powder, starch, sucrose, and maltose were purchased from Sigma-aldrich (St. Luis, MO, USA). Unless noted, all chemicals were purchased from Sigma-aldrich (St. Luis, MO, USA).
Preparation of Zingiber mioga extracts
Zingiber mioga was crushed to a fine powder and was extracted by autoclaving the ground leaves at 121 °C for 15 min with one gram-fresh weight per 40 mL of distilled water. Zingiber mioga extract was then centrifuged at 8000 x g for 30 min, filtered through a Whatman # 1 filter, vacuum-evaporated at 60 °C, freeze dried and kept at -20 °C refrigerator until analysis.
Zingiber mioga was crushed to a fine powder and was extracted by Shaking Incubation at 40 °C for 2 h with one gram-fresh weight per 40 mL of ethanol. Zingiber mioga extract was then centrifuged at 8000 x g for 30 min, filtered through a Whatman # 1 filter, vacuum-evaporated at 60 °C, freeze dried and kept at -20 °C refrigerator until analysis.
Carbohydrate hydrolyzing enzyme inhibition
Porcine pancreatic α–amylase inhibition assay
Porcine pancreatic α-amylase inhibition was determined by the method described by Kwon et al . Sample solution (200 μL) and 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M sodium chloride, 500 μL) containing α-amylase solution (0.5 mg/mL, 5.0 MU/mL) were incubated at 25 °C for 10 min. After pre-incubation, 500 μL of a 1 % starch solution in 0.02 M sodium phosphate buffer was added. The reaction mixture was then incubated at 25 °C for 10 min. The reaction was stopped with 1.0 mL of dinitrosalicylic acid (DNS). The reaction mixture was then incubated in a boiling water bath for 5 min and cooled to room temperature. The reaction mixture was then diluted after adding distilled water, and absorbance was measured at 540 nm with ELISA microplate reader (SUNRISE; Tecan Trading AG, Saltzburg, Austria).
Sucrase and Maltase inhibition assay
The crude enzyme solution prepared from rat intestinal acetone powder Sigma-Aldrich Co. (St. Louis, MO, USA) was used as the small intestinal maltase, sucrase, and glucoamylase, showing specific activities of 0.70, 0.34 and 0.45 units/mL, respectively. Rat intestinal acetone powder (1.0 g) was suspended in 3 mL of 0.9 % saline, and the suspension was sonicated twelve times for 30 s at 4 °C. After centrifugation (10,000 × g, 30 min, 4 °C), the resulting supernatant was used for the assay. Sucrase and maltase inhibitory activity were assayed by modifying a method developed by Dahlqvist (1964) . The inhibitory activity was determined by incubating a solution of an enzyme (50 μL), 0.1 M phosphate buffer (pH 7.0, 100 μL) containing 0.4 mg/mL sucrose or maltose or 1 % soluble starch, and a solution (50 μL) with various concentrations of sample solution (between 0.05 mM and 1.0 mM) at 37 °C for 30 min. The reaction mixture was heated in a boiling water bath to stop the reaction for 10 min, and then the amount of liberated glucose was measured by the glucose oxidase method . The inhibitory activity was calculated from the formula as follows. Inhibition (%) = (C-T)/C x 100, where C is the enzyme activity without inhibitor and T is the enzyme activity with inhibitor.
Oxygen radical absorbance capacity (ORAC) assay
The peroxyl radical-scavenging capacities of Zingiber mioga extracts were measured using ORAC [6, 7]. The ORAC assay was carried out using a Tecan GENios multi-functional plate reader (GENios; Tecan Trading AG, Salzburg, Austria) with fluorescent filters (excitation wavelength: 485 nm, emission filter: 535 nm). In the final assay mixture, fluorescein (40 nM) was used as a target of free radical attack with either 2, 2′-azobis (2-amidinopropane) dihydrochloride (AAPH, 20 mM) as a peroxyl radical generator in peroxyl radical-scavenging capacity (ORACROO·) assay or with H2O2 - CuSO4 (H2O2, 0.75 %; CuSO4, 5 μM) as a hydroxyl radical generator in hydroxyl radical-scavenging capacity (ORACHO·) assay. Trolox (1 μM) was used as a control standard and prepared fresh on a daily basis. The analyzer was programmed to record the fluorescence of fluorescein every 2 min after AAPH or H2O2 - CuSO4 was added. All fluorescence measurements were expressed relative to the initial reading. Final results were calculated based on the difference in the area under the fluorescence decay curve between the blank and each sample. All data were expressed as micromoles of Trolox equivalents (TE). One ORAC unit is equivalent to the net protection area provided by 1 μM of Trolox.
Total phenolic content assay
The total phenolic content was determined by an assay modified from Velioglu et al. [8, 9]. One milliter of sample solution was transferred into a test tube and mixed with 1 mL of 95 % ethanol and 5 mL of distilled water. To each sample 0.5 mL of 50 % (v/v) Folin-ciocalteu reagent was added and mixed. After 5 min, 1 mL of 5 % Na2CO3 was added to the reaction mixture and allowed to stand for 1 h. The absorbance was read at 725 nm using spectrophotometer (UV-160A; Shimadzu Inc., Kyoto, Japan). The absorbance values were converted to total phenolics and were expressed in mg equivalents of gallic acid/mL of the sample. Standard curves were established using various concentrations of gallic acid in 95 % ethanol.
Animal and study design
The inhibitory effect of Zingiber mioga extacts and acarbose on postprandial hyperglycemia after carbohydrate loads in Sprague-Dawley (SD) rats and C57BL/KsJ-db/db (db/db) mice were evaluated. The experimental protocols followed were approved by the Institutional Animal Care and Use Committee (IACUC) of the Hannam University (Approval number: HNU2015-0004). Five week-old male SD rats and C57BL/KsJ-db/db (db/db) mice were purchased from Joongang Experimental Animal Co. (Seoul, Korea) and fed a solid diet (Samyang Diet Co., Seoul, Korea) for 1 week. The rats and mice were housed in a ventilated room at 25 ± 2 °C with 50 ± 7 % relative humidity, and under an alternating 12 h light/dark cycle. After 4 groups of 5 male SD rats and db/db mice were fasted for 24 h, 2.0 g/kg of sucrose were orally administrated concurrently with 0 ~ 100 mg/kg inhibitors (Zingiber mioga extracts or Acarbose). The blood samples were then taken from the tail after administration and blood glucose levels were measured at 0, 0.5, 1, and 2 h. The glucose level in blood was determined by glucose oxidase method and compared with that of the control group, which had not taken the inhibitors.
All data are presented as mean ± Standard deviation (SD). Statistical analysis was carried out using statistical package SPSS 10 (Statistical Package for Social Science; SPSS Inc., Chicago, IL, USA) program and significance of each group was verified with the analysis of on-way analysis of variance (ANOVA) followed by the Duncan’s test of p < 0.05.
Results and discussion
Total phenolic contents in Zingiber mioga extracts
The total phenolic content in the two Zingiber mioga extracts (ZME; Ethyl alcohol extract of Zingiber mioga, ZMW; Water extract of Zingiber mioga) was evaluated. We determined that ZME had a total phenolic content of 2697.31 mg/100 g which was higher than ZMW (2182.96 mg/100 g) (Table 1). These results suggest that ethanol is a more efficient solvent for phenolic compounds extraction compared to water. Previous reports have shown that the total polyphenol contents in extracts has a positive correlation with observed anti-hyperglycemic activity in diabetic rats . Other studies using specific phenolic compound standards such as caffeic acid, catechins, anthocyanins, quercetins, and their derivatives confirmed their hypoglycemic effects in vitro and in vivo .
In vitro antioxidant capacity: peroxyl and hydroxyl radical scavenging capacity
The antioxidant activity of Zingiber mioga extracts was investigated for their radical-scavenging capacity using the ORAC assay system. Figure 1 demonstrates that the scavenging activity of Zingiber mioga extracts on peroxyl radicals generated from AAPH is dose-dependent at doses ranging from 1 to 10 μg/mL. The bars in Fig. 1a represent the ORAC ROO· activity of 1 μM of the tested sample equivalent to 1 μM Trolox, a water-soluble α-tocopherol analogue. The ORAC value for the sample extracts ranged from 0.53 ± 0.14 to 3.10 ± 0.10 μM of TE. At all tested doses, ZME exhibited higher scavenging activity on peroxyl radicals generated from AAPH compared to ZMW (Fig. 1a). Furthermore, we evaluated the hydroxyl radical absorbing activity (ORAC OH·) of ZME and ZMW using ORAC assay in which Cu2+ and H2O2 were used as hydroxyl radical generator. Similarly to our previous findings, ZME had higher scavenging activity compared to ZMW (Fig. 1b). Oxygen Radical Absorbance Capacity (ORAC) assay system has been used successfully to determine the reaction capacity with peroxyl radical, one of the harmful and reactive oxygen species in biological. ORAC assay has been employed widely in testing foods and beverages to provide an integrated and quantitative determination of “total antioxidant capacity” (TAC). The ORAC value is obtained by measuring the area under the curve (AUC) of the magnitude and time of inhibition of free radical attack on a fluorescent target molecule in reference to Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carbonyl acid) as a unit standard. Our findings suggest that the ethyl alcohol extract has higher antioxidant potential than the water extract. Phenolic compounds are well-documented radical scavengers and our findings (Fig. 1) correlate with the observed total phenolic contents (Table 1).
Sucrase and maltase inhibition
The dose-dependent sucrase inhibitory activities of ZME and ZMW were evaluated as outlined in materials and methods. The results showed that ZME exhibited significantly higher sucrase inhibitory activities (Fig. 2). More specifically, ZME had an IC50 value of 3.50 mg/mL, while ZMW had 4.91 mg/mL (Table 2). When maltase inhibitory activities were evaluated, similarly to sucrase inhibitory activity, ZME had higher maltase inhibitory activity (Fig. 3). More specifically, ZME and ZMW had IC50 values of 3.13 mg/mL and 3.99 mg/mL, repsectively (Table 2).
The enterocyte of the small intestine can only absorb monosaccharaides such as glucose and fructose from our diet. The intestinal absorption of dietary carbohydrates such as maltose and sucrose is supported by a group of α-glucosidases, which include intestinal maltase, sucrase, glucoamylase and isomaltase. Inhibition of these enzymes can significantly decrease the postprandial increase of blood glucose level after a mixed carbohydrate diet . Our results suggest that both extracts resulted to significant inhibition of the evaluated carbohydrate hydrolyzing enzymes. More specifically, when looking at the dose-dependent inhibitory activity, we can suggest that ZME had a higher inhibitory effect at the 5 mg/mL tested dose, which also results to a lower IC50 value. This observation could be due to the fact that ethanol extraction results to higher phenolic content when compared to the water extraction. Previous reports have clearly documented that carbohydrate hydrolyzing enzyme inhibitory activity depends on phenolic content .
α-Amylase Inhibition of Zingiber mioga extracts
The dose-dependent inhibitory activity of the Zingiber mioga extracts against porcine α-amylase was evaluated in this study. As seen in Fig. 4, both samples exhibited low α-amylase inhibitory activity, however ZME had a higher α-amylase inhibitory activity (16.44 ± 2.95 %) than ZMW (7.58 ± 2.28 %), (Fig. 1) at the same concentration (10 mg/mL).
α-Amylase inhibitors could slow the liberation of maltose from starch, resulting in delaying maltose conversion to glucose and decreasing postprandial plasma glucose levels. Previous reports with phenolic enriched herbal extracts reported a link between α-amylase and α-glucosidase inhibitory activity [3, 14]. All the herb extracts showed a comparable inhibition of α-glucosidase but did not have any inhibitory activity against porcine pancreatic α-amylase. Our findings are consistent with previous reports, since we observed significantly lower α-amylase inhibitory activity, compared to the sucrose and maltase inhibitory activities.
Sucrose loading test in SD Rat and db/db mice model
To confirm the in vivo relevance of our in vitro findings that ZME and ZMW extracts exhibited α-glucosidases inhibitory activities, we performed a sucrose loading test in SD rat, which is a model more relevant towards type 2 diabetes prevention with normal or pre-diabetic individuals, rather than type 2 diabetes treatments. In SD rats, ZME (0.1 g/kg) exerted a statistically significant decrease (p < 0.05) in the blood glucose at half an hour after sucrose loading. ZME significantly reduced (p < 0.05) the postprandial hyperglycemia caused by sucrose loading to an extent less than that observed in the acarbose (0.005 g/kg) administered group (p < 0.001) (Fig. 5). However, ZMW had no significant effect (Fig. 5).
Furthermore, we evaluated the effect of ZME and ZMW in 12 weeks db/db mouse model. Our observations suggested that ZME (0.1 g/kg) exerted a statistically significant decrease (p < 0.05) in the blood glucose at half an hour after sucrose loading (Fig. 6). Similarly to our previous observations using SD rat model, ZMW had no significant effect on the observed post-prandial blood glucose levels (Fig. 6).
Our results demonstrate the positive effects of ZME against post-prandial blood glucose levels resulting from high sucrose meal ingestion. Our in vivo findings, correlate with our in vitro observations, suggesting that ethanol alcohol extraction is more efficient than water extraction. More specifically, we have determined that ZME has higher phenolic content that results to a higher in vitro inhibition of carbohydrate hydrolyzing enzymes, when compared to ZMW. These observations translate to a higher in vivo efficacy of ZME.
A sudden increase in blood glucose levels, causing hyperglycemia in NIDDM is due to insulin’s inability to effectively utilize the glucose produced by the hydrolysis of dietary carbohydrates by carbohydrate hydrolyzing enzymes. Furthermore, hyperglycemia-induced microvascular complications are likely from oxidative dysfunction from mitochondrial reactive oxygen species (ROS). Therefore, it is important to control both cellular redox status and blood glucose level for managing these diabetic complications. The ethanol extract of Zingiber mioga has α-glucosidase inhibitory activity and potent peroxyl radical scavenging-linked antioxidant activity. Sucrose loading test showed that ZME may reduce postprandial increases of blood glucose level by acting as an intestinal α-glucosidase inhibitor. The above dual benefits (post-prandial blood glucose reduction and antioxidant activity) of ZME could support the evidence that diet rich in fruits and vegetables are associated with lower incidences of oxidation-linked diseases such as diabetes [15–17]. Furthermore, the Zingiber mioga extracts showed a strong inhibition of α-glucosidase and low inhibition of α-amylase and therefore could be potentially used as an effective complementary therapy for postprandial hyperglycemia linked to type2 diabetes with reduced side effects . It is well documented that the major side-effects of carbohydrate hydrolyzing enzyme inhibition are flatulence and diarrhea resulting from the high α-amylase inhibitory activity [19, 20].
These in vitro and in vivo studies provide the biochemical rationale for the potential benefit of Zingiber mioga for carbohydrate hydrolyzing enzyme inhibition, with ZME appearing to be more bioactive. This observed higher efficacy of ZME can be further enhanced by identifying the bioactive components responsible for the observed activity. Further investigation is underway to identify the specific phenolic compounds in Zingiber mioga extraction that are relevant to the inhibition of carbohydrate hydrolysis enzymes.
Availability of data and materials
All data and materials are contained and described within the manuscript.
Kurobayashi Y, Sakakibara H, Yanai T, Yajima I, Hayashi K. Volatile flavor compounds of myoga (Zingiber Mioga). Agric Biol Chem. 1991;55(6):1655–7.
Iwashita K, Yamaki K, Tsushida T. Mioga (Zingiber mioga Rosc.) Extract Prevents 3 T3-L1 Differentiation into Adipocytes and Obesity in Mice. Food Sci Technol Res. 2001;7(2):164–70.
Kwon YI, Vattem DA, Shetty K. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pac J Clin Nutr. 2006;15(1):107–18.
Dahlqvist A. Method for assay of intestinal disaccharidases. Anal Biochem. 1964;7(1):18–25.
Bergmeyer H, Bernt E. Determination of glucose with glucose oxidase and peroxidase. Methods Enzymatic Anal. 1974;2:1205–15.
Kurihara H, Fukami H, Asami S, Toyoda Y, Nakai M, Shibata H, Yao X-S. Effects of oolong tea on plasma antioxidative capacity in mice loaded with restraint stress assessed using the Oxygen Radical Absorbance Capacity (ORAC) assay. Biol Pharm Bull. 2004;27(7):1093–8.
Jo S, Ka E, Lee H, Apostolidis E, Jang H, Kwon Y. Comparison of antioxidant potential and rat intestinal a-glucosidases inhibitory activities of quercetin, rutin, and isoquercetin. Int J Appl Res Nat Prod. 2009;2(4):52–60.
Javanmardi J, Stushnoff C, Locke E, Vivanco JM. Antioxidant activity and total phenolic content of Iranian Ocimum accessions. Food Chem. 2003;83(4):547–50.
Muhammad I, Takamatsu S, Walker LA, Mossa JS, Fong HHS, El-Feraly FS. Cytotoxic and antioxidant activities of alkylated benzoquinones from Maesa lanceolata. Phytother Res. 2003;17(8):887–91.
Jo SH, Ha KS, Moon KS, Lee OH, Jang HD, Kwon YI. In vitro and in vivo anti-hyperglycemic effects of Omija (Schizandra chinensis) fruit. Int J Mol Sci. 2011;12(2):1359–70.
Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Med Cell Longev. 2009;2(5):270–8.
Hanamura T, Mayama C, Aoki H, Hirayama Y, Shimizu M. Antihyperglycemic effect of polyphenols from Acerola (Malpighia emarginata DC.) fruit. Biosci Biotechnol Biochem. 2006;70(8):1813–20.
Kim M-H, Jo S-H, Jang H-D, Lee M, Kwon Y-I. Antioxidant activity and α-glucosidase inhibitory potential of onion (Allium cepa L.) extracts. Food Sci Biotechnol. 2010;19(1):159–64.
Kim D-S, Kwon HJ, Jang H-D, Kwon Y-I. In vitro alpha-glucosidase inhibitory potential and antioxidant activity of selected Lamiaceae species inhabited in Korean Penninsula. Food Sci Biotechnol. 2009;18(1):239–44.
Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med. 1995;155(4):381–6.
Paganga G, Miller N, Rice-Evans CA. The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute? Free Radic Res. 1999;30(2):153–62.
Tadera K, Minami Y, Takamatsu K, Matsuoka T. Inhibition of alpha-Glucosidase and alpha-Amylase by Flavonoids. J Nutr Sci Vitaminol. 2006;52(2):149–53.
El-Demerdash FM, Yousef MI, El-Naga NI. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem Toxicol. 2005;43(1):57–63.
Bischoff H. Pharmacology of alpha-glucosidase inhibition. Eur J Clin Investig. 1994;24 Suppl 3:3–10.
Keup U, Puls W. Proceedings: metabolic studies with an amylase inhibitor (BAY e 4609). Naunyn Schmiedeberg’s Arch Pharmacol. 1975;287(Suppl):R85.
The authors declare that they have no competing interests.
SHJ and CYC conducted the animal experiment and analyzed the data. JYL and KSH prepared the product to be tested. EMA and YIK participated in design of the study and preparation of the manuscript. All the authors read and approved the final manuscript.